Several natural compounds found in health-related food items can inhibit acetyltransferases as they induce autophagy. Here we show that this applies to anacardic acid, curcumin, garcinol and spermidine, all of which reduce the acetylation level of cultured human cells as they induce signs of increased autophagic flux (such as the formation of green fluorescent protein-microtubuleassociated protein 1A/1B-light chain 3 (GFP-LC3) puncta and the depletion of sequestosome-1, p62/SQSTM1) coupled to the inhibition of the mammalian target of rapamycin complex 1 (mTORC1). We performed a screen to identify the acetyltransferases whose depletion would activate autophagy and simultaneously inhibit mTORC1. The knockdown of only two acetyltransferases (among 43 candidates) had such effects: EP300 (E1A-binding protein p300), which is a lysine acetyltranferase, and NAA20 (N(α)-acetyltransferase 20, also known as NAT5), which catalyzes the N-terminal acetylation of methionine residues. Subsequent studies validated the capacity of a pharmacological EP300 inhibitor, C646, to induce autophagy in both normal and enucleated cells (cytoplasts), underscoring the capacity of EP300 to repress autophagy by cytoplasmic (non-nuclear) effects. Notably, anacardic acid, curcumin, garcinol and spermidine all inhibited the acetyltransferase activity of recombinant EP300 protein in vitro. Altogether, these results support the idea that EP300 acts as an endogenous repressor of autophagy and that potent autophagy inducers including spermidine de facto act as EP300 inhibitors. Macroautophagy (herein referred to as 'autophagy') consist in the sequestration of cytoplasmic material in autophagosomes, followed by their fusion with lysosomes for the bulk degradation of autophagic cargo by lysosomal hydrolases.
Macroautophagy (herein referred to as 'autophagy') consist in the sequestration of cytoplasmic material in autophagosomes, followed by their fusion with lysosomes for the bulk degradation of autophagic cargo by lysosomal hydrolases. 1 This phenomenon can be measured by following the redistribution of green fluorescent protein-microtubule-associated protein 1A/1B-light chain 3 (GFP-LC3) fusion proteins from a diffuse location to autophagosomes (that results in the formation of the so-called GFP-LC3 'puncta'), the diminution of the overall abundance of autophagic substrates (such as sequestosome-1, p62/SQSTM1), and the stereotyped activation of proautophagic signals (such as the inhibition of the mammalian target of rapamycin complex 1, mTORC1). 2 There is growing consensus that the induction of autophagy by nutritional, pharmacological or genetic interventions can reduce age-related pathologies (such as neurodegenerative diseases or type 2 diabetes) and/or extend longevity. [3] [4] [5] [6] This applies to caloric restriction or intermediate fasting, 7 continuous or intermittent medication of rapamycin, [8] [9] [10] administration of the sirtuin 1-activator resveratrol, 11, 12 external supply of the polyamine spermidine, 13 or genetic ablation of p53.
14 In all these cases, inhibition of autophagy by deleting or silencing relevant genes abolishes the extension of health span and/or lifespan. [13] [14] [15] [16] [17] Moreover, direct induction of autophagy by transgenic expression of autophagy-relevant genes such as ATG5 in mice is sufficient to increase lifespan. 18 Recently, acetyltransferases have emerged as a potential target for the pharmaceutical induction of autophagy. Thus, depletion of the sole donor of acetyl groups, acetyl-coenzyme A (acetyl-CoA), is sufficient to reduce the acetylation of cytoplasmic and nuclear proteins coupled to the induction of autophagy. [19] [20] [21] [22] Culture of mammalian cells in nutrient-free (NF) conditions or starvation of mice for 24 h reduced the intracellular nucleocytosolic concentrations of acetyl-CoA at the same time as autophagy was induced, and replenishment of acetyl-CoA by external sources (for instance, by providing a membrane-permeant precursor of α-ketoglutarate for anaplerotic reactions or by microinjection of acetyl-CoA) was sufficient to inhibit starvation-induced autophagy. [19] [20] [21] [22] Beyond the inhibition of acetyltransferases by acetyl-CoA depletion, direct pharmacological inhibition of acetyltransferases might also contribute to the induction of autophagy. A close correlation between autophagy induction and deacetylation of cytoplasmic proteins was observed in a screen conceived to identify autophagy-stimulating polyphenols 23 as well as in in vivo experiments designed to explore the health-improving effects of coffee. 24 Spermidine turned out to be an efficient inhibitor of histone acetyltransferases in vitro 13 and reduced the global protein acetylation levels in cultured cells. 25, 26 Driven by these premises, we investigated the hypothesis that several health-related compounds including anacardic acid, curcumin, garcinol and spermidine might induce autophagy by inhibition of acetyltranferases. Here we report results supporting this hypothesis. Moreover, we demonstrate that one particular acetyltransferase, EP300 (E1A-binding protein p300), negatively controls autophagy and that anacardic acid, curcumin, garcinol and spermidine may induce autophagy by directly inhibiting EP300.
Results and discussion
Anacardic acid, curcumin, garcinol and spermidine induce autophagy and deacetylation of cellular proteins. Anacardic acid (6-pentadecyl-salicylic acid from the nutshell of the cashew, Anacardium occidentale), curcumin (from the South Asian spice turmeric, Curcuma longa, one of the principal ingredients of curry powder), garcinol (from the fruit of the Kokum tree, Garcina indica) or spermidine (a polyamine contained in all organisms, but found at particularly high concentrations in some health-related products such as durian fruit, fermented soybeans and wheat germs) were all able to stimulate the formation of GFP-LC3 puncta when added to human U2OS cells stably expressing this fluorescent biosensor (Figures 1a and b) . Induction of GFP-LC3 puncta was also observed in the presence of bafilomycin A1, a specific inhibitor of the vacuolar ATPase required for the fusion between autophagosomes and lysosomes (Figure 1c ), supporting the notion that these agents induce autophagic flux. 2 When added to nontransfected U2OS cells, anacardic acid, curcumin, garcinol and spermidine also stimulated the autophagy-associated lipidation of LC3, which increases its electrophoretic mobility to create the LC3-II form, in both the absence and presence of bafilomycin A1 (Figure 1d ), confirming that they induce autophagy. These results were confirmed in additional human cancer cell lines as well as in primary, non-transformed murine embryonic fibroblasts (Supplementary Figure 1) . Anacardic acid, curcumin, garcinol and spermidine also reduced the overall lysine acetylation of cellular proteins (Figures 2a and b) , determined by means of a protocol in which cells were fixed in such a way that the plasma membrane but not the nuclear envelope would be permeabilized, allowing a fluorescence-labeled antibody-recognizing proteins with acetylated lysines to gain access to the cytoplasm but not the nucleus. 23 The magnitude of deacetylation induced by these compounds correlated with their potential to induce autophagy ( Figure 2c ). Anacardic acid, curcumin, garcinol and spermidine also reduced the phosphorylation of S6RP (S6 ribosomal protein), a substrate of p70S6K (p70S6 kinase), which operates downstream of mTORC1, correlating with their autophagy-inducing capacity (Figures 2d-f) . Moreover, all the mentioned acetyltransferase inhibitors induced a significant reduction of p62/SQSTM1 levels, thus confirming (together with the results shown in (Figures 2g and h ). In this regard, we could observe that the reduction of cellular p62/SQSTM1 levels significantly correlated with the increase of GFP-LC3 puncta accumulation ( Figure 2i ). Altogether, these results reveal the ability of anacardic acid, curcumin, garcinol and spermidine to stimulate a stereotyped molecular cascade of biochemical events that resembles that induced by NF conditions: deacetylation of cellular proteins, inhibition of the mTORC1 pathway and induction of autophagy.
Identification of the acetyltransferase EP300 as a major endogenous repressor of autophagy. To identify the acetyltransferase(s) that control(s) autophagy, we systematically compared the capacity of pharmacological autophagy inducers to the small interfering RNA (siRNA)-mediated knockdown of 43 distinct gene products annotated as protein acetyltransferases with regard to four parameters: (i) induction of GFP-LC3 puncta in the presence of bafilomycin A1, (ii) reduction in the expression of the autophagic substrate p62/SQSTM1 in the absence of bafilomycin A1, (iii) dephosphorylation of s6RP and (iv) protein lysine deacetylation. Knockdown of only two acetyltransferases was able to induce the triad of GFP-LC3 puncta, p62/SQSTM1 depletion, and s6RP dephosphorylation. This applies to EP300, which is a lysine acetyltranferase, and NAA20, (N(α)-acetyltransferase 20, also known as NAT5), which catalyzes the N-terminal acetylation of methionine residues, an irreversible posttranscriptional modification, and not the reversible acetylation of N-ε-lysine groups. The absence of antibodies recognizing acetylated methionine prompted us to focus our studies on the characterization of EP300 activity. Knockdown of EP300 however failed to cause a significant decrease of protein lysine deacetylation (Figures 3a and b) . Moreover, we were unable to detect a correlation between overall protein acetylation levels, s6RP phosphorylation or p62/SQSTM1 cellular content and autophagy induction by the knockdown of individual acetyltransferases (Figures 3c-e) . This finding that may reflect the high specificity of such inhibitory manipulations, which target only one single acetyltransferase, compared with the chemical inhibitors, which likely target multiple acetyltransferases. Although knockdown of EP300 failed to reduce the overall acetylation status of cellular proteins (Figures 3a and b) , inhibition of EP300 by a 'specific' antagonist, C646, 27 did cause such an effect if used at a concentration of 10 μM (Figure 4a ). Careful dose-response studies, however, allowed us to dissociate the capacity of C646 to reduce protein acetylation and to induce GFP-LC3 puncta. At doses ranging from 300 nM to 1 μM, C646 did induce significant levels of LC3B puncta without causing detectable deacetylation of cellular proteins (Figures 4a and b) . Thus, the available data indicate that this compound is a more potent autophagy inducer (operating at an ED 50 of 1 μM) than any of the other chemicals used in this study, in line with the fact that C646 can inhibit EP300 at an ED 50 of 1 μM. 27 Moreover, truly selective inhibition of EP300 (by depletion with two non-overlapping siRNAs or by low-dose C646) could induce autophagy without causing global protein deacetylation. Importantly, C646 potently induced GFP-LC3 puncta with a similar efficiency in intact cells and in cytoplasts, that is, cells that have been enucleated (Figures 5a and b) , underscoring the possibility that EP300 mediates autophagy inhibition by cytoplasmic (non-nuclear, transcription-independent) effects. 28 Spermidine induces autophagy by inhibiting the acetyltransferase activity of EP300. Several of the chemical autophagy inducers used in this study have been described to inhibit EP300. This applies to anacardic acid, 29 curcumin, 30 garcinol 31 and C646. 27 However, spermidine, which is known to inhibit histone acetyltransferases in yeast (that lacks an EP300 ortholog), has not yet been evaluated for its capacity to interfere with the catalytic activity of EP300. In a cell-free system, spermidine inhibited the capacity of recombinant human EP300 protein to acetylate its substrate histone H3 (Figures 6a and b) . This effect was obtained at a physiological concentration of the acetyl donor acetyl-CoA of 10 μM, yet was attenuated when acetyl-CoA levels were raised 10-fold to 100 μM (Figures 6c and d and Supplementary Figure 2) , suggesting that spermidine acts as a competitive inhibitor, similar to the aforementioned agents.
27,29-31
Concluding remarks. The results in this paper underscore the notion that inhibitors of acetyltransferases act as potent autophagy inducers. Among the agents evaluated in this work, spermidine may represent the most attractive agent for therapeutic use, for multiple reasons. First, spermidine is a natural compound contained in all cells, including those of our body, which means that all mammals, including humans, physiologically dispose of an endogenous pool of this polyamine. Second, to date no adverse effects of exogenous supply of spermidine have been reported to the best of our knowledge. Third, spermidine has a broad longevityextending activity in multiple species from yeast to rodents. 13, [32] [33] [34] [35] Spermidine retards the manifestation of several major age-associated diseases including arterial aging, 36 colon cancer 37 and neurodegenerative processes in mice, 19, 38, 39 suggesting that it may be used for the prophylaxis of major age-related pathologies.
Here we report the evidence that spermidine may act as an autophagy inducer by virtue of its capacity to inhibit acetyltransferases. Beyond its capacity to reduce the overall levels of protein acetylation, spermidine also inhibits EP300, the acetyltransferase that physiologically acts as a sensor of nutrient-dependent acetyl-CoA levels 19 and that directly acetylates and inhibits several core autophagy proteins including ATG5, ATG7, ATG12 and LC3. 28 Thus, the autophagy-repressive activity of EP300 may not only depend on the intracellular concentration of acetyl-CoA but may also be regulated by the presence of spermidine (and likely other polyamines) that acts as a competitive inhibitor or its acetyltransferase activity. In fact, this is the first insight into the molecular mechanism(s) by which spermidine stimulates autophagic flux in mammalian cells. Further analyses on the capacity of spermidine to inhibit acetyltransferases should elucidate the mechanisms through which this polyamine exerts beneficial effects in diverse pathophysiological contexts. Furthermore, it may be tempting to develop new, truly specific EP300 inhibitors as investigational drugs andperhaps -new lead compounds for the therapeutic induction of autophagy.
Materials and Methods
Chemicals, cell lines and culture conditions. Unless otherwise specified, chemicals were purchased from Sigma-Aldrich (St. Louis, MO, USA), culture media and supplements for cell culture were from Gibco-Invitrogen (Carlsbad, CA, USA) and plasticware was from Corning (Corning, NY, USA). Human osteosarcoma U2OS cells and their GFP-LC3-expressing derivatives were cultured in DMEM medium containing 10% fetal bovine serum, 100 mg/l sodium pyruvate, 10 mM HEPES buffer, 100 U/ml penicillin G sodium and 100 mg/ml streptomycin sulfate (37°C, 5% CO 2 ). Cells were seeded in 6-and 12-well plates or in 10 and 15 cm dishes and grown for 24 h before treatment with 100 μM curcumin, 50 μM anacardic acid, 3 μM garcinol, 1 or 10 μM C646, 100 μM spermidine and 50 μM TSA. For serum and nutrient deprivation, cells were cultured in serum-free Earle's balanced salt solution.
RNA interference in human cell cultures. siRNAs were reverse transfected with the help of the RNAi MaxTM transfection reagent (Invitrogen, Eugene, OR, USA) according to the manufacturer's instructions. Sequences of the different siRNAs used in this study have been published previously. 19 Preparation of cytoplasts. U2OS cells stably expressing GFP-LC3 were trypsinized and incubated in 3 ml of complete medium supplemented with 7.5 mg/ml cytochalasin B for 45 min at 37°C. This cell suspension was layered onto a discontinuous Ficoll density gradient (3 ml of 55%, 1 ml of 90% and 3 ml of 100% Ficoll-Paques; GE Healthcare, Buckinghamshire, UK) in complete medium containing 7.5 mg/ml cytochalasin B. Gradients were prepared in ultracentrifuge tubes and pre-equilibrated at 37°C in a CO 2 incubator overnight. Gradients containing cell suspensions were centrifuged in a prewarmed rotor (SW41; Beckman Coulter, Brea, CA, USA) at 30 000 × g for 30 min at 32°C. The cytoplastenriched fraction was collected from the interface between 55 and 90% Ficoll layers, washed in complete medium and incubated for 4 h at 37°C before treatments.
Immunoblotting. For immunoblotting, 25 μg of proteins were separated on 4-12% Bis-Tris acrylamide (Invitrogen) or 12% Tris-Glycine SDS-PAGE precast gels (Bio-Rad, Hercules, CA, USA) and electrotransferred to Immobilon membranes (Millipore Corporation, Billerica, MA, USA). Membranes were then sliced into different parts according to the molecular weight of the protein of interest to allow simultaneous detection of different antigens within the same experiment. Unspecific binding sites were saturated by incubating membranes for 1 h in 0.05% Tween-20 (v : v in TBS) supplemented with 5% non-fat powdered milk (w : v in TBS), followed by an overnight incubation with primary antibody. Development was performed with appropriate horseradish peroxidase (HRP)-labeled secondary antibodies (Southern Biotech, Birmingham, USA) plus the SuperSignal West Pico chemoluminescent substrate (Thermo Scientific-Pierce). An anti-glyceraldehyde-3-phosphate dehydrogenase antibody (Chemicon International, Temecula, CA, USA) was used to control equal loading of lanes. Cell surfaces were segmented and divided into cytoplasmic and nuclear regions according to standard proceedings. RB 2 × 2 and Marr-Hildreth algorithms were used to detect cytoplasmic GFP-LC3-positive dots. Statistical analyses were conducted using the R software (http://www.r-project.org/). For quantitative analyses of protein acetylation, cell surfaces were segmented into cytoplasmic and nucleic regions, and average staining intensity of each individual cell was measured for statistical analysis.
Immunofluorescence. Cells were fixed with 4% PFA for 15 min at room temperature and permeabilized with 0.1% Triton X-100 for 10 min, except for staining of cytoplasmic acetyl-lysine-containing proteins, in which any permeabilization step further than PFA fixation was avoided. Nonspecific binding sites were blocked with 5% bovine serum albumin in PBS, followed by incubation with primary antibodies overnight at 4°C. Later, the cells were incubated with appropriate Alexa Fluor conjugates (Molecular Probes-Invitrogen, Eugene, OR, USA). In the case of cytoplasmic acetyl-lysine staining, an additional step of blocking using antiacetylated-tubulin antibody (1 : 200) was applied. Ten micromoles of Hoechst 33342 (Molecular Probes-Invitrogen) was used for nuclear counterstaining. Fluorescence wide-field and confocal microscopy assessments were performed on an DM IRE2 microscope (Leica Microsystems, Wetzlar, Germany) equipped with a DC300F camera and with an LSM 510 microscope (Carl Zeiss, Jena, Germany), respectively.
Fluorescence microscopy. Confocal fluorescence images were captured using a Leica TCS SPE confocal fluorescence microscope (Leica Microsystems). Non-confocal images were acquired with an Axio Observer inverted fluorescence microscope (Carl Zeiss). For experiments with human cell lines, a Leica APO x63 NA 1.3 immersion objective was used, whereas for the analysis of GFP-LC3 mice tissue sections, a Leica APO x40 NA 1.15 immersion objective was used. Zeiss Immersol immersion oil (Zeiss, Jena, Germany) was used for all microscopic analyses. Images were acquired with a Leica DFC 350 Fx camera (version 1.8.0) using Leica LAS AF software and processed with Adobe Photoshop (version CS2) software (Adobe Systems, San Jose, CA, USA).
In vitro acetylation assay. Recombinant GST-EP300 fusion protein, corresponding to amino acids 1066-1707 (14-418; Millipore, Billerica, MA, USA) was assessed for its acetyltransferase activity on the EP300 natural substrate recombinant histone H3 protein (M2503S; New England Biolabs, Ipswich, MA, USA). Briefly, 1 μg of EP300 HAT domain was incubated in the presence of an HAT assay buffer (250 mM Tris-HCl, pH 8.0, 50% glycerol, 0.5 mM EDTA and 5 mM dithiothreitol), 1 μg of histone H3 protein and 10 or 100 μM of acetyl-CoA (A2056; Sigma-Aldrich) for 1 h at 30°C. The reaction was stopped by adding 4x SDS buffer and boiling the samples. Acetylation of substrate proteins was measured by immunoblotting using specific antibodies against H3K56 (Cell Signaling, Danvers, MA, USA).
Statistical analyses. Unless otherwise mentioned, experiments were performed in triplicate and repeated at least two times. Data were analyzed using the GraphPad Prism 5 software (Graphpad software, La Jolla, CA, USA) and statistical significance was assessed by means of two-tailed Student's t-test or ANOVA tests, as appropriate.
